CO4230162A1 - Nuevos analogos de la doxiciclina que muestran actividad antibiotica contra una amplia gama de organismos gram-posi- tivos y gram-negativos incluidos organismos que son resis- tentes a antibioticos de tetraciclina - Google Patents

Nuevos analogos de la doxiciclina que muestran actividad antibiotica contra una amplia gama de organismos gram-posi- tivos y gram-negativos incluidos organismos que son resis- tentes a antibioticos de tetraciclina

Info

Publication number
CO4230162A1
CO4230162A1 CO95005921A CO95005921A CO4230162A1 CO 4230162 A1 CO4230162 A1 CO 4230162A1 CO 95005921 A CO95005921 A CO 95005921A CO 95005921 A CO95005921 A CO 95005921A CO 4230162 A1 CO4230162 A1 CO 4230162A1
Authority
CO
Colombia
Prior art keywords
gram
antibiotics
resistant
positive
wide range
Prior art date
Application number
CO95005921A
Other languages
English (en)
Inventor
Wei-Go Su
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of CO4230162A1 publication Critical patent/CO4230162A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/24—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
    • C07C237/26—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton of a ring being part of a condensed ring system formed by at least four rings, e.g. tetracycline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/40—Ortho- or ortho- and peri-condensed systems containing four condensed rings
    • C07C2603/42—Ortho- or ortho- and peri-condensed systems containing four condensed rings containing only six-membered rings
    • C07C2603/44—Naphthacenes; Hydrogenated naphthacenes
    • C07C2603/46—1,4,4a,5,5a,6,11,12a- Octahydronaphthacenes, e.g. tetracyclines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

ESTA INVENCION SE REFIERE A COMPUESTOS DE LA FOR- MULA FIGURA 1 EN DONDE R1, R2 Y R3 SE DEFINEN COMO EN LA MEMORIA DESCRIPTIVA Y LAS SALES ACEPTABLES FARMACEUTICA- MENTE DE TALES COMPUESTOS. LOS COMPUESTOS DE LA FORMULA I MUESTAN ACTIVIDAD ANTIBIOTICA CONTRA UNA AMPLIA GAMA DE ORGANISMOS GRAM-POSITIVOS, Y GRAM-NEGATIVOS, INCLUIDOS ORGA- NISMOS QUE SON RESISTENTES A ANTIBIOTICOS DE TE- TRACICLINA.
CO95005921A 1994-02-17 1995-02-16 Nuevos analogos de la doxiciclina que muestran actividad antibiotica contra una amplia gama de organismos gram-posi- tivos y gram-negativos incluidos organismos que son resis- tentes a antibioticos de tetraciclina CO4230162A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19880194A 1994-02-17 1994-02-17

Publications (1)

Publication Number Publication Date
CO4230162A1 true CO4230162A1 (es) 1995-10-19

Family

ID=22734909

Family Applications (1)

Application Number Title Priority Date Filing Date
CO95005921A CO4230162A1 (es) 1994-02-17 1995-02-16 Nuevos analogos de la doxiciclina que muestran actividad antibiotica contra una amplia gama de organismos gram-posi- tivos y gram-negativos incluidos organismos que son resis- tentes a antibioticos de tetraciclina

Country Status (12)

Country Link
US (1) US5834450A (es)
EP (1) EP0745065A1 (es)
JP (1) JP2784847B2 (es)
AU (1) AU1279095A (es)
BR (1) BR9500659A (es)
CA (1) CA2183565A1 (es)
CO (1) CO4230162A1 (es)
FI (1) FI950700A (es)
IL (1) IL112597A0 (es)
MX (1) MX9603508A (es)
PE (1) PE11196A1 (es)
WO (1) WO1995022529A1 (es)

Families Citing this family (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999037307A1 (en) * 1998-01-23 1999-07-29 Trustees Of Tufts College Pharmaceutically active compounds and methods of use thereof
MXPA02002595A (es) * 1999-09-14 2003-07-21 Tufts College Metodo para preparar tetraciclinas sustituidas con quimicas a base de metal de transicion.
US6849615B2 (en) 1999-09-14 2005-02-01 Paratek Pharmaceuticals, Inc. 13-substituted methacycline compounds
US6500812B2 (en) 1999-09-14 2002-12-31 Paratek Pharmaceuticals, Inc. 13-substituted methacycline compounds
US8106225B2 (en) * 1999-09-14 2012-01-31 Trustees Of Tufts College Methods of preparing substituted tetracyclines with transition metal-based chemistries
AU3105801A (en) * 2000-01-24 2001-07-31 Trustees Of Tufts College Tetracycline compounds for treatment of cryptosporidium parvum related disorders
MXPA02009482A (es) 2000-03-31 2004-05-14 Tufts College Compuestos tetraciclinas sustituidos con grupos 7- y 9- carbamato, urea, tiourea, tiocarbamato y heteroaril-amino.
AU2001259701A1 (en) 2000-05-15 2001-11-26 Paratek Pharmaceuticals, Inc 7-substituted fused ring tetracycline compounds
US20040224927A1 (en) * 2000-06-16 2004-11-11 Trustees Of Tufts College 7-N-substituted phenyl tetracycline compounds
US20020132798A1 (en) 2000-06-16 2002-09-19 Nelson Mark L. 7-phenyl-substituted tetracycline compounds
AU2001268475A1 (en) 2000-06-16 2002-01-02 Trustees Of Tufts College 7-phenyl-substituted tetracycline compounds
EA006170B1 (ru) 2000-07-07 2005-10-27 Трастис Оф Тафтс Коллидж Замещенные соединения тетрациклина (варианты), фармацевтическая композиция и способ лечения чувствительного к тетрациклину состояния субъекта
US7094806B2 (en) * 2000-07-07 2006-08-22 Trustees Of Tufts College 7, 8 and 9-substituted tetracycline compounds
EP2166000A1 (en) 2000-07-07 2010-03-24 Trustees Of Tufts College 7-, 8- and 9-substituted tetracycline compounds
PT1301467E (pt) 2000-07-07 2006-12-29 Tufts College Compostos de minociclina 9-substituídos
US20050143353A1 (en) * 2000-07-07 2005-06-30 Paratek Pharmaceuticals, Inc. 13-Substituted methacycline compounds
WO2002072506A2 (en) * 2001-03-13 2002-09-19 Paratek Pharmaceuticals, Inc. 7-pyrollyl tetracycline compounds and methods of use thereof
US7553828B2 (en) * 2001-03-13 2009-06-30 Paratek Pharmaceuticals, Inc. 9-aminomethyl substituted minocycline compounds
AU2001271619B2 (en) 2001-03-13 2008-05-15 Paratek Pharmaceuticals, Inc. 7, 9-substituted tetracycline compounds
EP1241160A1 (en) * 2001-03-13 2002-09-18 Glaxo Group Limited Tetracycline derivatives and their use as antibiotic agents
JP2004530661A (ja) * 2001-03-14 2004-10-07 パラテック ファーマシューティカルズ インコーポレイテッド 抗真菌剤としての置換テトラサイクリン化合物
CA2440757A1 (en) 2001-03-14 2002-09-19 Michael Draper Substituted tetracycline compounds as synergistic antifungal agents
US20040092490A1 (en) 2001-04-24 2004-05-13 Michael Draper Substituted tetracycline compounds for the treatment of malaria
US8088820B2 (en) * 2001-04-24 2012-01-03 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for the treatment of malaria
EP2332547A1 (en) 2001-07-13 2011-06-15 Paratek Pharmaceuticals, Inc. Tetracyclines for the treatment of inflammatory bowel disease
WO2003055441A2 (en) * 2001-08-02 2003-07-10 Paratek Pharmaceuticals, Inc. Medicaments
EP2311798A1 (en) 2002-01-08 2011-04-20 Paratek Pharmaceuticals, Inc. 4-dedimethylamino tetracycline compounds
EP2311451A1 (en) 2002-03-08 2011-04-20 Paratek Pharmaceuticals, Inc. Amino-methyl substituted tetracycline compounds
CA2479877C (en) 2002-03-21 2012-08-21 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds
AU2003261161B2 (en) 2002-07-12 2009-09-10 Paratek Pharmaceuticals, Inc 3, 10, and 12a substituted tetracycline compounds
WO2004038001A2 (en) 2002-10-24 2004-05-06 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for the treatment of malaria
JP4738333B2 (ja) 2003-07-09 2011-08-03 パラテック ファーマシューティカルズ インコーポレイテッド ９−アミノメチルテトラサイクリン化合物のプロドラッグ
EP2298322A3 (en) 2003-07-09 2011-05-11 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds
WO2005070878A1 (en) * 2004-01-15 2005-08-04 Paratek Pharmaceuticals, Inc. Aromatic a-ring derivatives of tetracycline compounds
US7807842B2 (en) 2004-05-21 2010-10-05 President And Fellows Of Harvard College Synthesis of tetracyclines and analogues thereof
AU2012202559B2 (en) * 2004-05-21 2014-07-17 President And Fellows Of Harvard College Synthesis of tetracyclines and analogues thereof
AU2014250722B2 (en) * 2004-05-21 2016-05-26 President And Fellows Of Harvard College Synthesis of tetracyclines and analogues thereof
TWI261038B (en) * 2004-08-11 2006-09-01 Bo-Cheng Chen Bicycle gear-shifting handgrip
AU2005299294B2 (en) 2004-10-25 2012-06-07 Paratek Pharmaceuticals, Inc. 4-aminotetracyclines and methods of use thereof
EP2284152A3 (en) 2004-10-25 2011-10-05 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds
EP1848686A2 (en) * 2005-02-15 2007-10-31 Wyeth 9-substituted tetracyclines
AR057033A1 (es) * 2005-05-27 2007-11-14 Wyeth Corp Tigeciclina y metodos para preparar 9-nitrominociclina
AR057034A1 (es) * 2005-05-27 2007-11-14 Wyeth Corp Metodos para purificar tigeciclina
AR057324A1 (es) * 2005-05-27 2007-11-28 Wyeth Corp Tigeciclina y metodos para preparar 9-aminominociclina
AR057032A1 (es) * 2005-05-27 2007-11-14 Wyeth Corp Tigeciclina y metodos de preparacion
US9192615B2 (en) 2008-08-06 2015-11-24 Medicis Pharmaceutical Corporation Method for the treatment of acne and certain dosage forms thereof
US8252776B2 (en) 2007-04-02 2012-08-28 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US20080241235A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US7919483B2 (en) * 2005-06-24 2011-04-05 Medicis Pharmaceutical Corporation Method for the treatment of acne
US20080242642A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US8722650B1 (en) 2005-06-24 2014-05-13 Medicis Pharmaceutical Corporation Extended-release minocycline dosage forms
US7541347B2 (en) * 2007-04-02 2009-06-02 Medicis Pharmaceutical Coropration Minocycline oral dosage forms for the treatment of acne
US7544373B2 (en) * 2007-04-02 2009-06-09 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
WO2007075792A1 (en) * 2005-12-22 2007-07-05 Wyeth Methods of treating gastrointestinal tract infections with tigecycline
EP1965770A2 (en) * 2005-12-22 2008-09-10 Wyeth a Corporation of the State of Delaware Oral formulations comprising tigecycline
CA2648668C (en) 2006-04-07 2015-06-23 The President And Fellows Of Harvard College Synthesis of tetracyclines and analogues thereof
AU2007249695A1 (en) 2006-05-15 2007-11-22 Paratek Pharmaceuticals, Inc. Methods of regulating expression of genes or of gene products using substituted tetracycline compounds
EP2076133B1 (en) 2006-10-11 2012-12-12 President and Fellows of Harvard College Synthesis of enone intermediate
SI2109602T1 (sl) * 2006-12-21 2014-06-30 Paratek Pharmaceuticals, Inc. Derivati tetraciklina za zdravljenje bakterijskih, virusnih in parazitskih infekcij
CA2673486C (en) * 2006-12-21 2015-09-08 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for treatment of inflammatory skin disorders
US20080241197A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline dosage forms for the treatment of acne
WO2008134048A2 (en) * 2007-04-27 2008-11-06 Paratek Pharmaceuticals, Inc. Methods for synthesizing and purifying aminoalkyl tetracycline compounds
PT2176216E (pt) * 2007-07-06 2012-07-27 Paratek Pharm Innc Métodos de síntese de minociclina substituída na posição 9
TW202021946A (zh) 2008-05-23 2020-06-16 美商派洛泰克藥物股份有限公司 四環素化合物之甲苯磺酸鹽及同素異形體
WO2010006292A1 (en) 2008-07-11 2010-01-14 Neumedics Tetracycline derivatives with reduced antibiotic activity and neuroprotective benefits
EP2323972B1 (en) 2008-08-08 2013-07-03 Tetraphase Pharmaceuticals, Inc. C7-fluoro substituted tetracycline compounds
EP2424834B1 (en) 2009-04-30 2018-07-11 President and Fellows of Harvard College Synthesis of tetracyclines and intermediates thereof
EP2427425B1 (en) 2009-05-08 2017-03-08 Tetraphase Pharmaceuticals, Inc. Tetracycline compounds
CA2772386C (en) 2009-08-28 2017-09-19 Tetraphase Pharmaceuticals, Inc. Tetracycline compounds
AU2011235176B2 (en) 2010-03-31 2015-05-14 Tetraphase Pharmaceuticals, Inc. Polycyclic tetracycline compounds
PT2707003T (pt) 2011-05-12 2019-08-05 Paratek Pharm Innc Sais cristalinos da amida do ácido (4s,4as,5ar,12as)-4-dimetilamino-3,10,12,12a-tetra-hidroxi-7-[(metoxi(metil)amino]-metil]-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octa-hidro-naftaceno-2-carboxílico e métodos de utilização dos mesmos
US9561241B1 (en) 2011-06-28 2017-02-07 Medicis Pharmaceutical Corporation Gastroretentive dosage forms for minocycline
ME03329B (me) 2012-08-31 2019-10-20 Tetraphase Pharmaceuticals Inc Jedinjenja tetraciklina
WO2014200213A1 (ko) * 2013-06-13 2014-12-18 한국생명공학연구원 테트라싸이클린 유도체, 이의 약학적으로 허용가능한 염 또는 이의 입체이성질체를 유효성분으로 함유하는 바이러스성 질환의 예방 또는 치료용 약학적 조성물
EP3529236B1 (en) 2016-10-19 2024-02-07 Tetraphase Pharmaceuticals, Inc. Crystalline forms of eravacycline
WO2020097450A1 (en) 2018-11-09 2020-05-14 Tetraphase Pharmaceuticals, Inc. Polymorphic forms of a compound and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3338963A (en) * 1960-10-28 1967-08-29 American Cyanamid Co Tetracycline compounds
DE1914194A1 (de) * 1968-03-25 1969-10-02 Pfizer & Co C Neue alpha-6-Deoxy-5-oxytetracycline
US5281628A (en) * 1991-10-04 1994-01-25 American Cyanamid Company 9-amino-7-(substituted)-6-demethyl-6-deoxytetracyclines
DE122006000058I2 (de) * 1991-10-04 2007-09-13 Wyeth Corp 7-Substituierte-9-substituierte Amino-6-Demethyl-6-Deoxy-Tetracycline
US5328902A (en) * 1992-08-13 1994-07-12 American Cyanamid Co. 7-(substituted)-9-[(substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines
US5371076A (en) * 1993-04-02 1994-12-06 American Cyanamid Company 9-[(substituted glycyl)amido]-6-(substituted)-5-hydroxy-6-deoxytetracyclines

Also Published As

Publication number Publication date
MX9603508A (es) 1997-03-29
IL112597A0 (en) 1995-05-26
US5834450A (en) 1998-11-10
PE11196A1 (es) 1996-04-12
CA2183565A1 (en) 1995-08-24
FI950700A0 (fi) 1995-02-16
JPH09501952A (ja) 1997-02-25
BR9500659A (pt) 1995-10-31
WO1995022529A1 (en) 1995-08-24
FI950700A (fi) 1995-08-18
JP2784847B2 (ja) 1998-08-06
EP0745065A1 (en) 1996-12-04
AU1279095A (en) 1995-09-04

Similar Documents

Publication Publication Date Title
CO4230162A1 (es) Nuevos analogos de la doxiciclina que muestran actividad antibiotica contra una amplia gama de organismos gram-posi- tivos y gram-negativos incluidos organismos que son resis- tentes a antibioticos de tetraciclina
CO4410333A1 (es) Derivados de quinazolina
KR950701911A (ko) 피페리딘 유도체를 유효성분으로 하는 말초혈관확장제(peripheral vaso-dilating agent containing piperidine derivative as active ingredient)
ES2164924T3 (es) Antibioticos de cefalosporina.
DK0673370T3 (da) Troponsubstituerede phenyloxazolidinoner som antibakterielle midler
KR930703355A (ko) 항생물질 ge2270 인자의 아미드
PA8451801A1 (es) Derivados de la 9-oxima eritromicina
DK0564924T3 (da) 2-Oxoethylderivater som immunosuppressiva
ES2187660T3 (es) Derivados de rapamicina.
ES2166379T3 (es) 2-aminotetralinas sustituidas.
TR200001330T2 (tr) Oksazolidinon türevleri ve farmasötik terkipler
AR029420A1 (es) Derivados de piperidiniloxi y pirrolidiniloxi oxazolidinona, un procedimiento para su preparacion, intermediarios y el uso de dichos derivados para la fabricacion de un medicamento antibacteriano
FI863836A (fi) Kinolinderivat.
ES2090083T3 (es) Derivados de cefalosporina, procedimiento para su preparacion y composicion antimicrobiana que contiene estos derivados.
CA1271747C (en) BENZAZEPINE DERIVATIVES
ES2161344T3 (es) Derivados oxazolin-amidicos basicos de los antibioticos ge2270 y similares.
ES2115424T3 (es) Derivados prolin-amidicos basicos de los antibioticos ge 2270 y similares a ge 2270.
SE7907547L (sv) 3", 4"-diacyltylosinderivat
AR025379A1 (es) 9a-azalidas con actividad antibacteriana.
AR007052A1 (es) Un derivado de carbohidrato, su uso y una composicion farmaceutica que lo comprende
ECSP951377A (es) Analogos de la doxiciclina
MC1615A1 (fr) Antibiotiques
ATE84535T1 (de) Polyaether-antibiotika.
ATE221378T1 (de) Pharmazeutische zusammensetzungen enthalten ceftriaxon und peneme
ES2113851T3 (es) Sales cristalinas estables y muy hidrosolubles antivirales de 2',3'-didesoxiinoxina monohidrato, 2',3'-didesoxi-2',3'-didehidrotimidina monohidrato y 2',3'-didesoxi-2'-fluoroinosina hemihidrato.